Scala Robert 4
4 · VACCINEX, INC. · Filed Sep 1, 2020
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Scala Robert
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-09-01+50,000→ 50,000 totalExercise: $5.67Exp: 2030-08-30→ Common Stock, par value $0.001 (50,000 underlying)
Footnotes (1)
- [F1]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the September 1, 2020 grant date.